Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Oncoimmunology|March 24, 2025
Cellular and secretome profiling uncover immunological biomarkers in the prognosis of renal cell carcinoma patientsLe Tong, Veronika Kremer, Shi Yong Neo, et al.
BMC Cancer|November 23, 2012
The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibitionChander Peddaboina, Daniel Jupiter, Steven Fletcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer CohortsArian Lundberg, Linda S Lindström, J Chuck Harrell, et al.
Breast Cancer Research : BCR|March 2, 2019
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumoursArian Lundberg, Linda S Lindström, Jingmei Li, et al.
Oncotarget|September 17, 2015
Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implicationsSiker Kimbung, Anikó Kovács, Anna Danielsson, et al.
Molecular Biology of the Cell|October 30, 2023
Differences in cell shape, motility, and growth reflect chromosomal number variations that can be visualized with live-cell ChReportersMichael P Tobin, Charlotte R Pfeifer, Peter Kuangzheng Zhu, et al.
Cancers|October 5, 2019
STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast CancerIoannis Zerdes, Majken Wallerius, Emmanouil G Sifakis, et al.
Cell Reports|August 25, 2021
The Amot/integrin protein complex transmits mechanical forces required for vascular expansionYuanyuan Zhang, Yumeng Zhang, Sumako Kameishi, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Chromosomal instability can favor macrophage-mediated immune response and induce a broad, vaccination-like anti-tumor IgG responseBrandon H Hayes, Mai Wang, Hui Zhu, et al.
Cell Death & Disease|March 8, 2024
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockadeNabanita Mukherjee, Elizabeth Katsnelson, Tonya M Brunetti, et al.
Pageof 14